Tarsus Pharmaceuticals (TARS) Shares Issued (2020 - 2025)
Historic Shares Issued for Tarsus Pharmaceuticals (TARS) over the last 6 years, with Q2 2025 value amounting to -$354000.0.
- Tarsus Pharmaceuticals' Shares Issued fell 2919.71% to -$354000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $45.8 million, marking a year-over-year increase of 4376571.43%. This contributed to the annual value of $9.4 million for FY2024, which is 85076.14% up from last year.
- Latest data reveals that Tarsus Pharmaceuticals reported Shares Issued of -$354000.0 as of Q2 2025, which was down 2919.71% from $135.1 million recorded in Q1 2025.
- Over the past 5 years, Tarsus Pharmaceuticals' Shares Issued peaked at $135.1 million during Q1 2025, and registered a low of -$98.4 million during Q4 2023.
- For the 5-year period, Tarsus Pharmaceuticals' Shares Issued averaged around $9.1 million, with its median value being -$3000.0 (2021).
- Per our database at Business Quant, Tarsus Pharmaceuticals' Shares Issued plummeted by 3353438.91% in 2022 and then surged by 75839230.77% in 2024.
- Quarter analysis of 5 years shows Tarsus Pharmaceuticals' Shares Issued stood at $221000.0 in 2021, then plummeted by 33534.39% to -$73.9 million in 2022, then crashed by 33.16% to -$98.4 million in 2023, then rose by 9.62% to -$88.9 million in 2024, then skyrocketed by 99.6% to -$354000.0 in 2025.
- Its last three reported values are -$354000.0 in Q2 2025, $135.1 million for Q1 2025, and -$88.9 million during Q4 2024.